Presentation by Dr David Raw, Deputy Divisional Medical Director, Aintree University Hospitals NHS Foundation Trust at the Emergency Laparotomy Collaborative, 13 November 2018 at Bolton Whites Hotel.
Professor Tony Marson - International Business Festival 2018Innovation Agency
Presentation by Professor Tony Marson, Professor of Neurology, University of Liverpool and The Walton Centre NHS Foundation Trust: Using routine data to plan and assess service performance at the International Business Festival 2018, 26 June, Exhibition Centre Liverpool
- Real-time monitoring of healthcare services requires defining both a reporting window and data window to accurately capture demand, activity, and wait times.
- Using only a reporting window (e.g. a single month) to request data can result in invalid or misleading performance metrics, as it does not account for patients with long wait times.
- Defining a larger data window that includes all patients requested before the end of the reporting window and reported after the start avoids this problem, but requires a counterintuitive data request.
- Without properly defining both windows, real-time monitoring can provide an inaccurate picture of service performance and falsely suggest the need for more resources.
Martin Utley, Director of the Clinical Operational Research Unit at University College London, reflects upon his involvement in the launch of specific tools to monitor care quality for paediatric cardiac surgery.
Aiming for a Higher Performing Health Care System: Learning from Cross-Nation...The Commonwealth Fund
Robin Osborn, Vice President and Director, International Program in Health Policy and Innovation at The Commonwealth Fund, discusses international health care systems. These slides were presented at the Queen’s Health Policy Change Conference, May 6, 2015 in Toronto, Canada.
Andrew Proctor, Sr. Director of Business Intelligence, Medical Operations Division, Cleveland Clinic
iHT2 case studies and presentations illustrate challenges, successes and various factors in the outcomes of numerous types of health IT implementations. They are interactive and dynamic sessions providing opportunity for dialogue, debate and exchanging ideas and best practices. This session will be presented by a thought leader in the provider, payer or government space.
This document summarizes Koonal Shah's presentation on developing a value set for the EQ-5D-Y, which is a youth version of the EQ-5D used to measure health outcomes in children and adolescents. Two studies are being conducted: 1) A discrete choice experiment with adults to obtain latent scale values for EQ-5D-Y health states. Preliminary findings show dimensions of pain, worry and activities are most important. 2) An anchoring study will interview adults and children to anchor the latent scale values at dead=0 using various valuation techniques. The goal is to produce a set of anchored values for the EQ-5D-Y to support its use in health technology assessment.
This document summarizes new methods for analyzing the distribution of EQ-5D health state observations. The objectives are to describe the distribution of health profiles within EQ-5D data, demonstrate differences between the 3L and 5L versions, and compare new methods to existing ones like the Shannon Index. Several new measures are introduced, including the Health State Density Curve and Index, which help show how a few profiles account for most observations. Results show the 5L has less clustered data than the 3L. The proportion of rare profiles increases with greater health gains after interventions. Overall, the new methods provide ways to systematically analyze and report the distribution of EQ-5D profile data.
Professor Tony Marson - International Business Festival 2018Innovation Agency
Presentation by Professor Tony Marson, Professor of Neurology, University of Liverpool and The Walton Centre NHS Foundation Trust: Using routine data to plan and assess service performance at the International Business Festival 2018, 26 June, Exhibition Centre Liverpool
- Real-time monitoring of healthcare services requires defining both a reporting window and data window to accurately capture demand, activity, and wait times.
- Using only a reporting window (e.g. a single month) to request data can result in invalid or misleading performance metrics, as it does not account for patients with long wait times.
- Defining a larger data window that includes all patients requested before the end of the reporting window and reported after the start avoids this problem, but requires a counterintuitive data request.
- Without properly defining both windows, real-time monitoring can provide an inaccurate picture of service performance and falsely suggest the need for more resources.
Martin Utley, Director of the Clinical Operational Research Unit at University College London, reflects upon his involvement in the launch of specific tools to monitor care quality for paediatric cardiac surgery.
Aiming for a Higher Performing Health Care System: Learning from Cross-Nation...The Commonwealth Fund
Robin Osborn, Vice President and Director, International Program in Health Policy and Innovation at The Commonwealth Fund, discusses international health care systems. These slides were presented at the Queen’s Health Policy Change Conference, May 6, 2015 in Toronto, Canada.
Andrew Proctor, Sr. Director of Business Intelligence, Medical Operations Division, Cleveland Clinic
iHT2 case studies and presentations illustrate challenges, successes and various factors in the outcomes of numerous types of health IT implementations. They are interactive and dynamic sessions providing opportunity for dialogue, debate and exchanging ideas and best practices. This session will be presented by a thought leader in the provider, payer or government space.
This document summarizes Koonal Shah's presentation on developing a value set for the EQ-5D-Y, which is a youth version of the EQ-5D used to measure health outcomes in children and adolescents. Two studies are being conducted: 1) A discrete choice experiment with adults to obtain latent scale values for EQ-5D-Y health states. Preliminary findings show dimensions of pain, worry and activities are most important. 2) An anchoring study will interview adults and children to anchor the latent scale values at dead=0 using various valuation techniques. The goal is to produce a set of anchored values for the EQ-5D-Y to support its use in health technology assessment.
This document summarizes new methods for analyzing the distribution of EQ-5D health state observations. The objectives are to describe the distribution of health profiles within EQ-5D data, demonstrate differences between the 3L and 5L versions, and compare new methods to existing ones like the Shannon Index. Several new measures are introduced, including the Health State Density Curve and Index, which help show how a few profiles account for most observations. Results show the 5L has less clustered data than the 3L. The proportion of rare profiles increases with greater health gains after interventions. Overall, the new methods provide ways to systematically analyze and report the distribution of EQ-5D profile data.
The document discusses the medical knowledge sharing platform DailyRounds. It provides information on how doctors use the platform to share clinical cases, challenge themselves and colleagues, and track scores. Statistics are given on the large number of new doctors, cases, social media followers, and high ratings. The document also mentions features like access to doctors, e-detailing, pharma analytics, and goals for expanding specialties, global reach, and industry partnerships in the next year.
This document discusses administrative issues in emergency departments. It provides statistics on the growth and importance of emergency medicine as a specialty and the role of emergency departments in hospitals. It notes that emergency departments see a high volume of patients, often with high acuity, and generate a significant portion of hospital activity, funding, and physician full-time equivalents. The document also discusses perceptions of risk in emergency medicine and examines exam pass rates and allegations of institutional racism regarding emergency medicine certification exams.
This document discusses using direct-to-patient research methods to improve clinical trials. It notes that direct engagement of patients can lead to faster enrollment, increased retention, and decreased costs compared to traditional physician-centric models. However, it also notes limitations such as potential questions about data quality without physician involvement. The document presents several case studies showing how direct-to-patient approaches have been used successfully in multiple sclerosis, gout, and other disease areas to collect patient-reported outcomes and validate diagnoses while engaging patients.
The Australian e-Health Research Centre is Australia's leading national eHealth research centre with around 60-70 staff. It is partnered with CSIRO, Queensland Health, and other engagement partners from government and industry. The Centre conducts research in biomedical imaging, mobile and tele-health, and health informatics to improve health systems and services through technologies like analytics, modeling, decision support, and telehealth. Specifically, it is running an NBN telehealth trial across six Australian sites to test the impact of telehealth on 150 test patients and 300 control patients.
This document describes the development of an electronic workflow system called scope to improve surgical practice at a District Health Board (DHB) hospital. The goals were to seamlessly map the patient journey, accurately collect coded data, and leverage trusted data to inform clinicians. The system streamlines waiting lists, captures accurate operating notes, and facilitates morbidity and mortality meetings. Implementation across surgical specialties has achieved good compliance and uptake. Preliminary results found increased quality of notes, discussion of complications, and potential to change practice through advanced data analysis. In conclusion, scope has replaced a disconnected paper system with a seamless electronic solution that fully captures standardized data to improve surgical outcomes.
The document discusses technology-enabled care in Scotland and its potential role in improving healthcare delivery. It outlines Scotland's national programs in telehealth, telecare, and telemedicine. It also discusses organizational efforts to standardize clinical and technological approaches, share expertise, and evaluate new projects. The goal is to provide more effective and sustainable community-based care through remote monitoring and virtual consultations in order to reduce hospital admissions and lengths of stay.
Monitoring quality of care: making the most of dataNuffield Trust
Chris Sherlaw-Johnson, Senior Research Analyst at the Nuffield Trust, introduced the Monitoring quality of care conference and gives an overview of some of the approaches that we've been using at the Trust to identify where care quality has been improving, especially for frail and older people.
Real World Evaluation and implementation of a diagnostic test for pre-eclampsiaWalt Whitman
The document discusses a case study evaluating the real-world implementation of a diagnostic test for pre-eclampsia across 7 hospitals in the Thames Valley region, with the goals of standardizing adoption of preeclampsia testing to improve patient safety, clinical capacity, reduce unnecessary admissions, and lower overall system costs.
Diabetic eye screening 1 April 2015 to 31 March 2016 data slide setMike Harris
This document provides charts and data to support the annual NHS Diabetic Eye Screening Programme report for the period of April 1, 2015 to March 31, 2016. It includes information on eligible patients, screening outcomes, referrals to eye hospitals, and notes on data quality for individual screening services. Definitions of key terms and codes for the 90 screening services across England are also provided.
The document provides updates on several UK screening programs, including:
1) Styayb leaflets and audio files for screening during pregnancy.
2) Changes to SCT (sickle cell and thalassaemia) screening including remembering to identify the biological father and new screening standards.
3) Stories from women who accepted or declined prenatal diagnosis after screening, and clinical/service audits.
4) Updates on IDPS (infectious disease in pregnancy) screening including data workshops, resources, and known hepatitis B positive referral timeframes.
5) New standards for DESP (diabetes in early pregnancy) screening and coverage seen within 6 weeks of pregnancy notification.
Lisa Annaly, Head of Provider Analytics at the Care Quality Commission, discusses lessons learned from the CQC as they have worked to monitor care quality over time.
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
Record of NHS Screening e-learning completionMike Harris
This document records Jonathan Waldheim's completion of various e-learning modules related to NHS screening programmes. It shows the dates that modules within different screening program topics were completed, including antenatal and newborn screening, sickle cell and thalassaemia screening, newborn blood spot screening, fetal anomaly scanning, nuchal translucency screening, sickle cell and thalassaemia laboratory techniques, newborn hearing screening, newborn and infant physical examination, abdominal aortic aneurysm screening, and 18-20 week fetal anomaly ultrasound scanning. The document provides details on over 50 individual e-learning modules and the dates they were completed from 2014 to 2017.
Dr Nic Woods discusses tools for early recognition and management of sepsis using the electronic medical record (EMR). Sepsis poses a major global health challenge and burden. Tools discussed include a sepsis predictive model built into the EMR that can detect signs of sepsis with sensitivities of 68-91% and specificities of 91-97.6%. Clinical decision support and workflows in the EMR are also used to alert clinicians and guide treatment. Evaluations found these tools helped reduce mortality from sepsis by 4.2-17% and lower length of hospital stays. Key points emphasized that predictive models integrated into clinical workflows can positively impact outcomes, but more progress is still needed.
Alere's vision is to connect all of healthcare through care coordination and collaboration. Their solution aims to provide access to a patient's complete medical history across all providers to improve care. This is done by applying best medical guidelines, engaging physicians and patients through alerts and recommendations, and achieving better health outcomes through adherence to plans and protocols. Alere's platform and analytics provide actionable recommendations and alerts to physicians and patients based on 30,000 evidence-based rules. This is intended to reduce errors, improve outcomes, enhance efficiency and manage costs.
AHP Unscheduled Care Event 2019 (Morning Session)AHPScot
The document discusses the vital role that allied health professionals (AHPs) play in unscheduled care. It notes that AHPs are an essential group that can support six essential actions to improve unscheduled care. The document highlights several ways that AHPs can make a difference at various points along the patient journey from the ambulance service through the acute setting. It also discusses some of the challenges around patient flow and reasons for delays in discharging patients. Overall, the document emphasizes the importance of AHPs and having the right staff with the right skills in the right places to effectively support patients through the unscheduled care pathway.
This document discusses the differences between the EQ-5D-3L and EQ-5D-5L health-related quality of life instruments. It notes that the 5L was developed to address concerns with the 3L, including reduced ceiling effects and better discrimination among patient subgroups. While the 3L is still commonly used, studies show the 5L provides improvements. A challenge is that switching between the 3L and 5L is likely to affect quality-adjusted life year (QALY) estimates and healthcare technology assessments. The sources of differences between the instruments relate to how patients respond to the questionnaires as well as how general public preferences are valued.
Tomasz Sablinski from Transparency Life Sciences showed at the DayOne Expert event - Next Generation Clinical Trials ways to virtualize clinical trials or parts of them.
Challenges and improvements in diagnostic services across seven day services NHS Improving Quality
Prof Erika Denton, National Clinical Director for Diagnostics. Slides from Erika's presentation at the 7 Day services events in West Midlands 11th June and East Midlands 12th June, 2014.
Cancer patients’ experiences in one tertiary referral emergency department (E...Cancer Institute NSW
The demand on Australian EDs has increased by an average of 4.2% each year while the cancer incidence rate has doubled since 1991. Many patients with cancer present to EDs but may be better managed using alternative healthcare models.
The document discusses the medical knowledge sharing platform DailyRounds. It provides information on how doctors use the platform to share clinical cases, challenge themselves and colleagues, and track scores. Statistics are given on the large number of new doctors, cases, social media followers, and high ratings. The document also mentions features like access to doctors, e-detailing, pharma analytics, and goals for expanding specialties, global reach, and industry partnerships in the next year.
This document discusses administrative issues in emergency departments. It provides statistics on the growth and importance of emergency medicine as a specialty and the role of emergency departments in hospitals. It notes that emergency departments see a high volume of patients, often with high acuity, and generate a significant portion of hospital activity, funding, and physician full-time equivalents. The document also discusses perceptions of risk in emergency medicine and examines exam pass rates and allegations of institutional racism regarding emergency medicine certification exams.
This document discusses using direct-to-patient research methods to improve clinical trials. It notes that direct engagement of patients can lead to faster enrollment, increased retention, and decreased costs compared to traditional physician-centric models. However, it also notes limitations such as potential questions about data quality without physician involvement. The document presents several case studies showing how direct-to-patient approaches have been used successfully in multiple sclerosis, gout, and other disease areas to collect patient-reported outcomes and validate diagnoses while engaging patients.
The Australian e-Health Research Centre is Australia's leading national eHealth research centre with around 60-70 staff. It is partnered with CSIRO, Queensland Health, and other engagement partners from government and industry. The Centre conducts research in biomedical imaging, mobile and tele-health, and health informatics to improve health systems and services through technologies like analytics, modeling, decision support, and telehealth. Specifically, it is running an NBN telehealth trial across six Australian sites to test the impact of telehealth on 150 test patients and 300 control patients.
This document describes the development of an electronic workflow system called scope to improve surgical practice at a District Health Board (DHB) hospital. The goals were to seamlessly map the patient journey, accurately collect coded data, and leverage trusted data to inform clinicians. The system streamlines waiting lists, captures accurate operating notes, and facilitates morbidity and mortality meetings. Implementation across surgical specialties has achieved good compliance and uptake. Preliminary results found increased quality of notes, discussion of complications, and potential to change practice through advanced data analysis. In conclusion, scope has replaced a disconnected paper system with a seamless electronic solution that fully captures standardized data to improve surgical outcomes.
The document discusses technology-enabled care in Scotland and its potential role in improving healthcare delivery. It outlines Scotland's national programs in telehealth, telecare, and telemedicine. It also discusses organizational efforts to standardize clinical and technological approaches, share expertise, and evaluate new projects. The goal is to provide more effective and sustainable community-based care through remote monitoring and virtual consultations in order to reduce hospital admissions and lengths of stay.
Monitoring quality of care: making the most of dataNuffield Trust
Chris Sherlaw-Johnson, Senior Research Analyst at the Nuffield Trust, introduced the Monitoring quality of care conference and gives an overview of some of the approaches that we've been using at the Trust to identify where care quality has been improving, especially for frail and older people.
Real World Evaluation and implementation of a diagnostic test for pre-eclampsiaWalt Whitman
The document discusses a case study evaluating the real-world implementation of a diagnostic test for pre-eclampsia across 7 hospitals in the Thames Valley region, with the goals of standardizing adoption of preeclampsia testing to improve patient safety, clinical capacity, reduce unnecessary admissions, and lower overall system costs.
Diabetic eye screening 1 April 2015 to 31 March 2016 data slide setMike Harris
This document provides charts and data to support the annual NHS Diabetic Eye Screening Programme report for the period of April 1, 2015 to March 31, 2016. It includes information on eligible patients, screening outcomes, referrals to eye hospitals, and notes on data quality for individual screening services. Definitions of key terms and codes for the 90 screening services across England are also provided.
The document provides updates on several UK screening programs, including:
1) Styayb leaflets and audio files for screening during pregnancy.
2) Changes to SCT (sickle cell and thalassaemia) screening including remembering to identify the biological father and new screening standards.
3) Stories from women who accepted or declined prenatal diagnosis after screening, and clinical/service audits.
4) Updates on IDPS (infectious disease in pregnancy) screening including data workshops, resources, and known hepatitis B positive referral timeframes.
5) New standards for DESP (diabetes in early pregnancy) screening and coverage seen within 6 weeks of pregnancy notification.
Lisa Annaly, Head of Provider Analytics at the Care Quality Commission, discusses lessons learned from the CQC as they have worked to monitor care quality over time.
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
Record of NHS Screening e-learning completionMike Harris
This document records Jonathan Waldheim's completion of various e-learning modules related to NHS screening programmes. It shows the dates that modules within different screening program topics were completed, including antenatal and newborn screening, sickle cell and thalassaemia screening, newborn blood spot screening, fetal anomaly scanning, nuchal translucency screening, sickle cell and thalassaemia laboratory techniques, newborn hearing screening, newborn and infant physical examination, abdominal aortic aneurysm screening, and 18-20 week fetal anomaly ultrasound scanning. The document provides details on over 50 individual e-learning modules and the dates they were completed from 2014 to 2017.
Dr Nic Woods discusses tools for early recognition and management of sepsis using the electronic medical record (EMR). Sepsis poses a major global health challenge and burden. Tools discussed include a sepsis predictive model built into the EMR that can detect signs of sepsis with sensitivities of 68-91% and specificities of 91-97.6%. Clinical decision support and workflows in the EMR are also used to alert clinicians and guide treatment. Evaluations found these tools helped reduce mortality from sepsis by 4.2-17% and lower length of hospital stays. Key points emphasized that predictive models integrated into clinical workflows can positively impact outcomes, but more progress is still needed.
Alere's vision is to connect all of healthcare through care coordination and collaboration. Their solution aims to provide access to a patient's complete medical history across all providers to improve care. This is done by applying best medical guidelines, engaging physicians and patients through alerts and recommendations, and achieving better health outcomes through adherence to plans and protocols. Alere's platform and analytics provide actionable recommendations and alerts to physicians and patients based on 30,000 evidence-based rules. This is intended to reduce errors, improve outcomes, enhance efficiency and manage costs.
AHP Unscheduled Care Event 2019 (Morning Session)AHPScot
The document discusses the vital role that allied health professionals (AHPs) play in unscheduled care. It notes that AHPs are an essential group that can support six essential actions to improve unscheduled care. The document highlights several ways that AHPs can make a difference at various points along the patient journey from the ambulance service through the acute setting. It also discusses some of the challenges around patient flow and reasons for delays in discharging patients. Overall, the document emphasizes the importance of AHPs and having the right staff with the right skills in the right places to effectively support patients through the unscheduled care pathway.
This document discusses the differences between the EQ-5D-3L and EQ-5D-5L health-related quality of life instruments. It notes that the 5L was developed to address concerns with the 3L, including reduced ceiling effects and better discrimination among patient subgroups. While the 3L is still commonly used, studies show the 5L provides improvements. A challenge is that switching between the 3L and 5L is likely to affect quality-adjusted life year (QALY) estimates and healthcare technology assessments. The sources of differences between the instruments relate to how patients respond to the questionnaires as well as how general public preferences are valued.
Tomasz Sablinski from Transparency Life Sciences showed at the DayOne Expert event - Next Generation Clinical Trials ways to virtualize clinical trials or parts of them.
Challenges and improvements in diagnostic services across seven day services NHS Improving Quality
Prof Erika Denton, National Clinical Director for Diagnostics. Slides from Erika's presentation at the 7 Day services events in West Midlands 11th June and East Midlands 12th June, 2014.
Cancer patients’ experiences in one tertiary referral emergency department (E...Cancer Institute NSW
The demand on Australian EDs has increased by an average of 4.2% each year while the cancer incidence rate has doubled since 1991. Many patients with cancer present to EDs but may be better managed using alternative healthcare models.
This document discusses quality improvement in healthcare. It begins by posing questions about defining quality, what quality improvement is, and how quality can be improved. It then discusses the safety paradox in healthcare - that despite highly trained staff and technology, errors are common and patients are frequently harmed. Several studies on adverse event rates in hospitals are summarized. The document discusses concepts for safety and quality improvement like reliability, variation, measurement, and change management. It provides examples of quality improvement tools and approaches like process mapping, care bundles, measurement, and the PDSA (Plan-Do-Study-Act) cycle. Overall, the document provides an overview of key issues and approaches related to quality and safety in healthcare.
The document discusses the Vascular Quality Initiative (VSGNE), a regional collaborative focused on improving vascular care quality through data collection and analysis. Key points:
- VSGNE was founded in 2001 with 9 hospitals and has grown to include 30 hospitals. It collects detailed clinical data on over 33,000 procedures to track outcomes and drive quality improvement.
- Semi-annual meetings bring surgeons together to discuss benchmarked results, stimulate cooperative projects, and overcome insular practices. Regional analysis of variations in processes and outcomes identifies areas for improvement.
- Examples of quality improvements include increased pre-op statin use, reduced restenosis rates through increased carotid patching, and more accurate cardiac risk prediction models - all leading
Stroke Event 13 Sep - First morning presentationsCLAHRC-NDL
This document summarizes research on early supported discharge (ESD) services for stroke patients. The research aimed to evaluate whether the benefits of ESD seen in clinical trials are still evident in practice. The study compared outcomes for 135 patients receiving ESD services to 158 patients receiving usual care without ESD following a stroke. Results showed that the ESD group had significantly shorter hospital lengths of stay and were more knowledgeable about community support services. Statistical modeling also found that ESD patients were more likely to score higher on measures of independence at 6 weeks, 6 months and 12 months post-stroke. The research provides real-world evidence that ESD services continue to provide benefits for stroke rehabilitation compared to usual care without ESD support.
Dr Nick Selby - AKI detection, alerting and intervention-محول.pptxinfoomallps
This document summarizes research on acute kidney injury (AKI) conducted by Dr. Nick Selby and colleagues. It finds that AKI is common, occurring in 5-15% of hospital admissions, and associated with high mortality, especially for more severe cases. While electronic detection of AKI has improved, outcomes depend on bundled interventions like diagnosis, fluid management, and medication review. Large trials show electronic alerts with care bundles can reduce AKI duration and hospital length of stay, though not mortality. Ongoing research aims to better characterize AKI subtypes and predict non-recovery risk to guide new therapies.
Martin Bardsley: integration and innovation in healthNuffield Trust
This document summarizes two case studies that used retrospective evaluations of existing administrative data to assess the impact of healthcare interventions. The first case study evaluated the Marie Curie Nursing Service and found it significantly increased home deaths and reduced hospital admissions and costs at end of life. The second case study evaluated eight community interventions under the Partnerships for Older People Projects but found none reduced hospital use as anticipated. Both cases highlighted strengths and limitations of using retrospective evaluations of routine data to assess healthcare interventions.
Jane Blower, Deputy Chief Scientific Officer (Acting) NHS England. Jane's presentation from the Seven Day Services event in the East Midlands on 12th June 2014.
The document discusses challenges in healthcare transitions and coordination between different providers. It proposes a new model of care for hip and knee replacements that includes centralized intake clinics, case managers, data-informed quality measures, and case rate funding. The model aims to improve outcomes, efficiency, and reduce delays. It also describes programs for fragility fractures and hip replacements that have improved access to surgery and reduced lengths of stay.
Ian Blunt & Martin Bardsley: Cause for concernQualityWatch
This document summarizes the work of the Nuffield Trust and Health Foundation's QualityWatch program, which monitors and comments on the quality of health and social care in the UK. The program uses indicators to measure changes in quality over time, conducts in-depth analyses on specific topics, publishes an annual report, and maintains a website. The 2014 annual statement expressed concerns that quality appears to be declining in some areas like access to services and staff stress levels, while mental health and equity issues remain problematic. The statement analyzed trends in these areas and posed questions about addressing gaps in performance, targeting support, and improving quality measurement.
InfCareHIV is a clinical decision support system and quality assurance registry for HIV care in Sweden. It covers over 99% of HIV patients nationally, with data on 7838 living patients and 12936 total patients registered. The system is used at each patient visit to automatically transfer lab and quality of life data between clinics. It produces real-time statistics on HIV care in Sweden and delivers anonymized data to international collaborators for research. InfCareHIV also supports pharmaceutical studies through patient identification and data sharing.
Parallel Session 2.8 SEPSIS and VTE Collaborative – Breakthrough Series Colla...NHSScotlandEvent
The document discusses the Sepsis/VTE Collaborative. It explains that the collaborative was formed to improve sepsis and venous thromboembolism (VTE) management. It describes initial tests of changing documentation and assessing patients for sepsis that were conducted. Baseline data was collected on 18 patients with high early warning scores, of which 9 had new septic episodes. The median time to first antibiotics for septic patients was reduced from 1 hour and 25 minutes pre-intervention to 37 minutes post-intervention with the introduction of a dual response system in one respiratory ward area. Balancing measures such as antibiotic usage were also tracked.
National Comparative Audit of Lower Gastrointestinal Bleeding and the Use of Blood: Findings and Interpretations
This audit examined practice and outcomes for 2,528 patients admitted with lower gastrointestinal bleeding (LGIB) across 143 UK hospitals. Key findings included inappropriate transfusion in 27% of patients, only 26% receiving endoscopy within 24 hours, and 49% having no investigations to identify the bleeding source. Performance was compared against 17 evidence-based standards, identifying opportunities for improvement particularly around medicines management and timely investigation. Interpretations highlighted the benefits of centralized specialized care for LGIB patients, including more consistent guideline-based care, regular auditing, teaching and lower costs through reduced variation.
National Comparative Audit of Lower Gastrointestinal Bleeding and the Use of ...Raimundas Lunevicius
This audit shows that there is no such thing as acute upper gastrointestinal (UGI) bleeding or acute lower gastrointestinal (LGI) bleeding. There is acute gastrointestinal (GI) bleeding, which predominantly is one of a few emergency gastroenterological conditions. In other words, a historic agreement between clinical directors to direct a patient presenting with hematemesis to gastroenterology ward & to direct another patient with PR bleed to Emergency General Surgery Ward is not quite logical, as PR bleeding is one of the signs of acute UGI as well as LGI bleeding.
The concentration of patients in one highly specialized unit for GI bleeding management WITHIN GASTROENTEROLOGY CENTRE is the second summary key point of this audit.
I do think that Gastroenterology Ward would be the best Ward to concentrate all patients presenting with signs of GI bleeding, for a mean patient presenting with this problem is:
(1) An elderly patient with significant comorbidities, often taking a so-called ‘blood thinner’ (aspirin, NSAIDs, and even steroids),
(2) Requiring limited volume blood transfusions - sometimes,
(3) Requiring radiological and endoscopic investigations within 24 hours / in a case of clinically significant bleeding,
(4) Not requiring urgent surgery in the absolute majority of the cases (5 emergency laparotomies in all four countries of the UK), and (5) Not having a clinical diagnosis on the day of discharge.
Objective
Safer Healthcare Now!, a program of the Canadian Patient Safety Institute, invites you to participate in the Canadian VTE Audit, designed to establish a national perspective of VTE thromboprophylaxis rates and raise awareness of appropriate VTE prophylaxis.
VTE is one of the most common and preventable complications of hospitalization and is a Required Organizational Practice (ROP) of Accreditation Canada.
By participating in the national audit day you will be a part of a movement aimed at preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in hospital patients.
Watch the recording: http://bit.ly/1wfinCE
Lisa Hancock OIG Board Quality PresentationLisa Hancock
IU Medical Group's quality improvement goals are to decrease mortality and morbidity, increase patient satisfaction, improve patient safety, and link these goals to management accountability. Metrics such as UHC reports and patient satisfaction surveys are used to measure progress. Clinical department chairs must annually report progress on these goals to the board. The organization utilizes numerous quality reports and surveys to measure and improve patient care. Each clinical department is responsible for quality and safety programs within their department.
How diagnostics can drive efficiency within the NHSWalt Whitman
This document summarizes a presentation on how diagnostics can drive efficiency within the NHS. It notes that demand for diagnostic tests and waiting lists have increased in recent years without equivalent funding growth. Wide variation exists in diagnostic quality and access across regions. The presentation calls for diagnostics to be optimized by reducing unwarranted variation, improving data sharing and digital infrastructure, addressing capacity issues, and incentivizing efficiency. Recent NHS data collection and modeling identified over 30 million fewer tests, £33.6 million in cost savings, and opportunities to standardize practices and reduce costs in imaging services.
Similar to Introduction - The Emergency Laparotomy Collaborative (20)
This document provides a summary of a presentation on statins. It discusses the benefits of statins in reducing cardiovascular events and mortality in both primary and secondary prevention. It addresses several controversies around statins, including their association with diabetes, cognitive impairment, cancer, and hemorrhagic stroke. While some modest risks are noted, the overall benefits of statins in reducing cardiovascular risk are found to outweigh these potential risks. The document emphasizes the importance of statin adherence to achieve optimal outcomes and addresses targets for LDL and non-HDL cholesterol levels according to recent guidelines.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
Developing Effective Remote Consultations in Outpatients webinarInnovation Agency
1) The document discusses strategic plans to increase the use of virtual appointments through video to help restore NHS services and reduce backlogs as directed nationally.
2) Data is presented on the percentage of virtual vs face-to-face appointments by specialty for different regions, showing variation between specialties and trusts in uptake of virtual appointments.
3) Interviews were conducted with NHS staff across roles and specialties to understand the reasons for the differences in uptake of virtual appointments and identify barriers to wider adoption. A separate report from patient interviews also provided feedback.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
The document discusses strategies for effective virtual collaboration using Zoom. It covers:
1. Getting familiar with basic Zoom functions and pushing boundaries to achieve results through techniques like choosing the right technology, managing time and atmosphere, addressing technical issues, and designing for inclusivity.
2. Methods for collecting data virtually through polling software, informal tools like chat and reactions, and creative approaches like using glass jars, mountains, push pins, and post-its for feedback.
3. The importance of incorporating fun and enjoyment into virtual meetings by setting challenges, using stories, sharing passions, and exploring improv to promote effective learning.
The document discusses restorative practices and community circles. It provides information on the core principles and processes of restorative circles, including their purposes, structural elements, characteristics, and stages. Circles are presented as an alternative to traditional hierarchical meetings and aim to allow all voices, build relationships, and develop understanding and solutions. Indigenous justice practices of restoration and healing are also honored.
The document outlines an agenda for a webinar hosted by the Innovation Scout network. It will include an introduction to the Innovation Scout network, a presentation from an advocacy link worker, a Q&A session, and wrap up. Attendees are encouraged to tweet with specific hashtags and email the contact for follow up discussions. The Innovation Scout network is a community of practice that was relaunched in 2019 to support innovation in health and social care through tools, culture change, entrepreneurial skills development, and networking. It has over 80 members across the North West Coast region working on healthcare innovation.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Debunking Nutrition Myths: Separating Fact from Fiction"AlexandraDiaz101
In a world overflowing with diet trends and conflicting nutrition advice, it’s easy to get lost in misinformation. This article cuts through the noise to debunk common nutrition myths that may be sabotaging your health goals. From the truth about carbohydrates and fats to the real effects of sugar and artificial sweeteners, we break down what science actually says. Equip yourself with knowledge to make informed decisions about your diet, and learn how to navigate the complexities of modern nutrition with confidence. Say goodbye to food confusion and hello to a healthier you!
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Jim Jacob Roy
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
2. On the menu today…
13:30 Introduction: NELA update and NW performance
Dr David Raw Anaesthetist
13:40 The ELC: KSS perspective
Jo Wookey- Improvement Lead
14:00 What’s working well locally?
Mr Paul Goldsmith UGI Surgeon
14:20 Importance of data
Dr David Raw
14:30 Supporting data collection and analysis
Dr Matt Bridge Anaesthetist
14:40 Round table discussion
15:40 Patient Safety Collaborative
Ass. Directors Andrew Cooper (Innovation Agency)
and Jay Hamilton (Health Innovation Manchester)
16:00 Close
3. NELA
• Centrally funded National Clinical Audit Project
• Aim to improve care through high quality
comparative data between hospitals
• Contract for provision of NELA won by RCOA 2012.
Data collection commenced Dec 2013.
• Data collection describing processes and outcomes
• Compared to standards of care
• 4 annual reports 2015, 2016, 2017, 2018
• 4th report published 8th Nov 2018 (2016-17 data)
4. Number of standards being met
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
Year 1
Number of standards met
NumberofhospitalsratedGreen
5. Number of standards being met
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
Year 1
Year 2
Number of standards met
NumberofhospitalsratedGreen
6. Number of standards being met
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
Year 1
Year 2
Year 3
Number of standards met
NumberofhospitalsratedGreen
12. Introduction of new Best Practice Tariff
2019/21
For high risk EL patients (mortality >5%?)
>80% of eligible patients (NELA data) must receive BOTH:
• Consultant Surgeon and Anaesthetist presence in theatre
for high risk cases
– NW data: 11/25 Trusts with <85% of cases (amber/red rated)
• Critical care admission from theatre for high risk cases
– NW Data: 11/25 Trusts with <85% of cases (amber/red rated)
15/25 Trusts are amber/red rated for one or other of
these metrics.
The 4th report collected data form 25,000 cases of the 30,000 emergency laparotomies performed in England and Wales.
182 Trusts
Improvements seen during the course of the audit in LoS and 30-day mortality.
The 3rd report collected data form 24,000 cases of the 30,000 emergency laprotomies performed in England and Wales.
Improvements seen during the course of the audit in LoS and 30-day mortality.
183/191 hospitals in England and Wales
Patients more likely to arrive in theatre within accepted time frame at night. ?pressures of flow during the day??
There appears to be a variation in outcme measures.
NHSi and NHS England appear to be impatient for QI in Emerg Lap care….